A Double-Blinded, Placebo-Controlled Trial to Investigate Dexlansoprazole for the Treatment of Laryngopharyngeal Reflux.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2013
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 01 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 23 Mar 2011 New trial record